COMMENT ON MITOXANTRONE

被引：14

作者：

DUKART, G ^{[1
]}

IATROPOULOS, MJ ^{[1
]}

YACOBI, A ^{[1
]}

机构：

[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 03期

关键词：

D O I：

10.1177/106002808501900317

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：216 / 218

页数：3

共 14 条

[1] ADAMSON RH, 1974, CANCER CHEMOTH REP 1, V58, P293
[2] SERIAL ASSESSMENT OF DOXORUBICIN CARDIOTOXICITY WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY
ALEXANDER, J
DAINIAK, N
BERGER, HJ
GOLDMAN, L
JOHNSTONE, D
REDUTO, L
DUFFY, T
SCHWARTZ, P
GOTTSCHALK, A
ZARET, BL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) : 278 - 283
[3] BENJAMIN RS, 1984, MAY AM SOC CLIN ONC
[4] MITOXANTRONE - A REPLACEMENT FOR DOXORUBICIN
CONNER, CS
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 479 - 480
[5] COMPARATIVE CARDIAC OXYGEN RADICAL METABOLISM BY ANTHRACYCLINE ANTIBIOTICS, MITOXANTRONE, BISANTRENE, 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE, AND NEOCARZINOSTATIN
DOROSHOW, JH
DAVIES, KJA
[J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) : 2935 - 2939
[6] DOROSHOW JH, 1983, CANCER RES, V43, P4543
[7] DUKART G, 1984, PHARMANUAL COMPREHEN
[8] FENOGLIO JJ, 1983, CARDIOVASC PATHOL, V2, P1085
[9] HENDERSON IC, 1984, MAY AM SOC CLIN ONC
[10] IATROPOULOS MJ, 1984, CANCER TREAT S, V3, P380